检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

First-in-human study of an OX40 (ivuxolimab) and 4-1BB (utomilumab) agonistic antibody combination in patients with advanced solid tumors.

Omid Hamid,Alberto A Chiappori,John A Thompson,Toshihiko Doi,Siwen Hu-Lieskovan,Ferry A L M Eskens,Willeke Ros,Adi Diab,Jean-Philippe Spano,Naiyer A Rizvi,Jeffrey S Wasser,Eric Angevin,Patrick A Ott,Alison Forgie,Wenjing Yang,Cen Guo,Jeffrey Chou, Anthony B El-Khoueiry

Journal for immunotherapy of cancer（2022）

引用 15|浏览15
暂无评分
摘要
NCT02315066.
更多
查看译文
关键词
Drug Therapy, Combination,Immunomodulation,Immunotherapy,Therapies, Investigational
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要